Highlights: Global TB funding cuts risk undoing decades of progress in TB elimination Drug-resistant TB cases ma
Vous n'êtes pas connecté
The fight against drug-resistant tuberculosis (TB) has taken a significant leap forward with recent findings from a clinical trial involving the oral antibiotic levofloxacin. Conducted by researchers at the University of Sydney’s Woolcock Institute of Medical Research in collaboration with the Vietnam Tuberculosis Program, the trial has demonstrated the efficacy and safety of levofloxacin in […]
Highlights: Global TB funding cuts risk undoing decades of progress in TB elimination Drug-resistant TB cases ma
A Phase 3 trial for the tuberculosis vaccine known as M72/AS01E is running a year ahead of schedule and has already recruited 90% of the 20,000 people...
A Phase 3 trial for the tuberculosis vaccine known as M72/AS01E is running a year ahead of schedule and has already recruited 90% of the 20,000 people...
A Phase 1 clinical trial for a Lassa virus (LASV) vaccine has been developed by a team of researchers from Thomas Jefferson University, in...
China’s self-developed novel tuberculosis mRNA vaccine started a clinical trial at Beijing Chest Hospital on Monday, according to the local...
China’s self-developed novel tuberculosis mRNA vaccine started a clinical trial at Beijing Chest Hospital on Monday, according to the local...
The Ministry of Health, alongside key stakeholders, has reaffirmed its commitment to combating tuberculosis (TB) as the world observes World...
The Ministry of Health, alongside key stakeholders, has reaffirmed its commitment to combating tuberculosis (TB) as the world observes World...